Cargando…

Angiotensin receptor-neprilysin inhibitor in patients with heart failure and chronic kidney disease

Despite significant advances in the management of heart failure with reduced ejection fraction (HFrEF), there remains an enormous health problem with high morbidity and mortality over the last few decades. The neprilysin inhibitor enhances the activity of natriuretic peptides, producing vasodilation...

Descripción completa

Detalles Bibliográficos
Autores principales: Cho, In-Jeong, Kang, Seok-Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society of Nephrology 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8685363/
https://www.ncbi.nlm.nih.gov/pubmed/34922429
http://dx.doi.org/10.23876/j.krcp.21.900

Ejemplares similares